Piccirillo MC, Chu Q, Bradbury P, Tu W, et al. Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171). J Thorac Oncol 2023;18:813-819.
PMID: 36841541